Furthermore, we are focusing on executing successful launches of both Monjuvi and Pemazyre, and we expect Tabrecta royalties to increase following the approvals and subsequent launches by Novartis in both the U.S. and Japan.
Take context from the input text and decide on the accurate relationship between 'Tabrecta' and 'Novartis' from the options provided.
Options: owner of, manufacturer, location of formation, operator